1. Home
  2. Analysis
  3. Imodium
  4. Basaglar

Imodium and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Basaglar (insulin glargine). Common drug interactions include retinopathy among females and lacrimation increased among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Basaglar. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Mar, 24, 2026

40 people who take Imodium and Basaglar together, and have interactions are studied.

Imodium and Basaglar drug interactions.

What are the common drug interactions of Imodium and Basaglar, by gender? *:

female:

  1. Retinopathy (acute damage to the retina of the eye)
  2. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  3. Vitamin b complex deficiency
  4. Wrist fracture
  5. Headache (pain in head)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Back pain
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Death
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Lacrimation increased
  2. Peripheral swelling
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Photosensitivity reaction
  5. Skin depigmentation (lightening of the skin)
  6. Blister infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Bone disorder
  8. Cardiac disorder
  9. Device failure
  10. Eye injury

What are the common drug interactions of Imodium and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Lacrimation increased
  2. Peripheral swelling
  3. Alopecia (absence of hair from areas of the body)
  4. Anaemia (lack of blood)
  5. Fatigue (feeling of tiredness)
  6. Hair colour changes
  7. Joint swelling
  8. Poor quality sleep
  9. Rash
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

40-49:

n/a

50-59:

  1. Abdominal pain upper
  2. Blood glucose increased
  3. Cardiac failure congestive
  4. Chest discomfort
  5. Colitis (inflammation of colon)
  6. Cough
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dyspnoea (difficult or laboured respiration)
  9. Eating disorder
  10. Flatulence (flatus expelled through the anus)

60+:

  1. Death
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blindness unilateral
  4. Bradycardia (abnormally slow heart action)
  5. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Diabetes mellitus inadequate control
  8. Diabetic glaucoma (disease that damages the eye's optic nerve caused by diabetes)
  9. Ejection fraction decreased (systolic heart failure)
  10. Enterovirus infection

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 15.00%
  2. Gastrointestinal Stromal Tumor: 6 people, 15.00%
  3. Type 2 Diabetes: 2 people, 5.00%
  4. Renal Cell Carcinoma (a kidney cancer): 2 people, 5.00%
  5. Pancreatic Neuroendocrine Tumor: 2 people, 5.00%
  6. Multiple Allergies (allergy to multiple agents): 2 people, 5.00%
  7. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 5.00%
  8. High Blood Pressure: 2 people, 5.00%
  9. Diabetes: 2 people, 5.00%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium and Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Basaglar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and insulin glargine (the active ingredients of Imodium and Basaglar, respectively), and Imodium and Basaglar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.